Deltex1 antagonizes HIF-1α and sustains the stability of regulatory T cells in vivo

Abstract

Application of regulatory Tcells (Tregs) in transplantation, autoimmunity and allergy has been extensively explored, but how Foxp3 and Treg stability is regulated in vivo is incompletely understood. Here, we identify a requirement for Deltex1 (DTX1), a contributor to T-cell anergy and Foxp3 protein level maintenance in vivo. Dtx1-/-Tregs are as effective as WT Tregs in the inhibition of CD4+CD25- T-cell activation in vitro. However, the suppressive ability of Dtx1-/- Tregs is greatly impaired in vivo. We find that Foxp3 expression is diminished when Dtx1-/- Tregs are co-transferred with effector Tcells in vivo. DTX1 promotes the degradation of HIF-1α. Knockout of HIF-1α restores the Foxp3 stability and rescues the defective suppressive activity in Dtx1-/- Treg cells in vivo. Our results suggest that DTX1 exerts another level of control on Treg stability in vivo by sustaining the expression of Foxp3 protein in Tregs.